个人中心 - 老虎社区

Raywjj92

IP属地：未知

帖子 · 6帖子 · 6
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- Raywjj92Raywjj92
  ·2021-05-02
  Time to play the game
  3 of Cathie Wood's Biggest Losers of 2021 That Should Still Be Huge Long-Term Winners<blockquote>凯西·伍德 (Cathie Wood) 2021 年最大的 3 个输家仍然应该是巨大的长期赢家</blockquote>
  David Gardner, a co-founder of The Motley Fool, often says that "winners win." And he's exactly righ
  3 of Cathie Wood's Biggest Losers of 2021 That Should Still Be Huge Long-Term Winners<blockquote>凯西·伍德 (Cathie Wood) 2021 年最大的 3 个输家仍然应该是巨大的长期赢家</blockquote>
  1,672 评论
  2
  分享
  举报
- Raywjj92Raywjj92
  ·2021-05-02
  Nice detailed article
  非常抱歉，此主贴已删除
  2,260 评论
  1
  分享
  举报
- Raywjj92Raywjj92
  ·2021-05-01
  Good opportunity?
  非常抱歉，此主贴已删除
  2,034 2
  3
  分享
  举报
- Raywjj92Raywjj92
  ·2021-05-01
  $Qualcomm(QCOM)$Come on Qualcomm
  1,757 评论
  1
  分享
  举报
- Raywjj92Raywjj92
  ·2021-04-28
  Nice article
  5 Ultra-Popular Growth Stocks With 28% to 56% Upside, According to Wall Street<blockquote>华尔街称 5 只超受欢迎的成长型股票，上涨空间为 28% 至 56%</blockquote>
  For 13 months, Wall Street has proved virtually unstoppable. Since hitting a bear market bottom on M
  5 Ultra-Popular Growth Stocks With 28% to 56% Upside, According to Wall Street<blockquote>华尔街称 5 只超受欢迎的成长型股票，上涨空间为 28% 至 56%</blockquote>
  1,567 评论
  点赞
  分享
  举报
- Raywjj92Raywjj92
  ·2021-02-12
  Great article
  非常抱歉，此主贴已删除
  1,967 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3575030447100890","uuid":"3575030447100890","gmtCreate":1611936560419,"gmtModify":1619620831004,"name":"Raywjj92","pinyin":"raywjj92","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/57550c84d835f65dcf57fd3bf7c5d66b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":15,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":6,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.07.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.07","exceedPercentage":"60.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":101497940,"gmtCreate":1619928874980,"gmtModify":1631885488646,"author":{"id":"3575030447100890","authorId":"3575030447100890","name":"Raywjj92","avatar":"https://static.tigerbbs.com/57550c84d835f65dcf57fd3bf7c5d66b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575030447100890","authorIdStr":"3575030447100890"},"themes":[],"title":"","htmlText":"Time to play the game&nbsp;","listText":"Time to play the game&nbsp;","text":"Time to play the game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/101497940","repostId":"1115363330","repostType":4,"repost":{"id":"1115363330","kind":"news","pubTimestamp":1619791216,"share":"https://www.laohunote.com/m/news/1115363330?lang=zh_CN&edition=full","pubTime":"2021-04-30 22:00","market":"us","language":"en","title":"3 of Cathie Wood's Biggest Losers of 2021 That Should Still Be Huge Long-Term Winners<blockquote>凯西·伍德 (Cathie Wood) 2021 年最大的 3 个输家仍然应该是巨大的长期赢家</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1115363330","media":"Motley Fool","summary":"David Gardner, a co-founder of The Motley Fool, often says that \"winners win.\" And he's exactly righ","content":"<p>David Gardner, a co-founder of The Motley Fool, often says that \"winners win.\" And he's exactly right. However, he would be the first to tell you that winners don't win<i>all</i>of the time. They have their ups and downs.</p><p><blockquote>Motley Fool 的联合创始人大卫·加德纳 (David Gardner) 经常说“赢家获胜”。他说得完全正确。然而，他会第一个告诉你胜利者不会赢<i>全部</i>那个时候。他们有起起落落。</blockquote></p><p> Case in point: Cathie Wood certainly qualifies as a winner. Her ARK Invest exchange-traded funds have ranked among the best-performing ETFs in recent years. Not every stock in those funds has delivered a great return so far in 2021, though.</p><p><blockquote>典型的例子：凯西·伍德当然有资格成为赢家。她的 ARK Invest 交易所交易基金是近年来表现最好的 ETF 之一。不过，2021 年迄今为止，并非这些基金中的每只股票都能带来丰厚的回报。</blockquote></p><p> Several of the ARK Invest CEO's favorites are actually down year to date. Don't count all of those recent underperformers out just yet, though. These three are among Wood's biggest losers of 2021, and all should still be huge winners over the long run.</p><p><blockquote>ARK Invest 首席执行官最喜欢的几只股票实际上今年迄今为止都在下跌。不过，不要把最近表现不佳的公司都算在内。这三个人是伍德2021年最大的输家之一，从长远来看，他们都应该是巨大的赢家。</blockquote></p><p> Teladoc Health</p><p><blockquote>泰拉多克健康</blockquote></p><p> <b>Teladoc Health</b>(NYSE:TDOC)shares have fallen more than 15% year to date, and that's weighing on several of Wood's ETFs. Teladoc is the top holding in the<b>ARK Genomic Revolution ETF</b>, the second-largest position in the<b>ARK Innovation ETF</b>, and the fifth-largest holding in the<b>ARK Next Generation Internet ETF</b>.</p><p><blockquote><b>泰拉多克健康</b>（纽约证券交易所股票代码：TDOC）今年迄今已下跌超过 15%，这给伍德的几只 ETF 带来了压力。Teladoc 是最大的控股公司<b>方舟基因组革命 ETF</b>，第二大位置<b>方舟创新ETF</b>以及第五大持股<b>方舟下一代互联网ETF</b>.</blockquote></p><p> It appears that many investors are focusing only on the negatives for Teladoc. For example,in its Q1 update, the company reported a huge net loss and said that U.S. paid membership in the quarter slipped to 51.5 million from 51.8 million in the fourth quarter of 2020.</p><p><blockquote>许多投资者似乎只关注 Teladoc 的负面影响。例如，在第一季度更新中，该公司报告了巨额净亏损，并表示本季度美国付费会员从 2020 年第四季度的 5180 万下滑至 5150 万。</blockquote></p><p> However, that's only part of the story. Teladoc's total visits and utilization rate continue to climb. And much of that big loss was related to the company's acquisitions of Livongo and InTouch Health, deals that are already helping drive its revenue growth.</p><p><blockquote>然而，这只是故事的一部分。Teladoc 的总访问量和利用率持续攀升。这一巨额亏损很大程度上与该公司收购 Livongo 和 InTouch Health 有关，这些交易已经帮助推动了其收入增长。</blockquote></p><p> My view is that Teladoc's downturn will be temporary. The long-term opportunities for the company in virtual care remain exceptionally strong.</p><p><blockquote>我认为 Teladoc 的低迷将是暂时的。该公司在虚拟护理领域的长期机会仍然异常强劲。</blockquote></p><p> Unity Software</p><p><blockquote>Unity软件</blockquote></p><p> <b>Unity Software</b>(NYSE:U)has been an especially poor performer for Wood this year -- the stock has plunged more than 30%. The gaming platform leader ranks No. 10 among the ARK Next Generation Internet ETF's holdings and No. 12 for the ARK Innovation ETF.</p><p><blockquote><b>Unity软件</b>（纽约证券交易所股票代码：U）今年的表现尤其糟糕——该股已暴跌超过 30%。这家游戏平台领导者在方舟下一代互联网 ETF 持有的股票中排名第 10，在方舟创新 ETF 中排名第 12。</blockquote></p><p> The main knock against Unity is its slowing growth rate. In the fourth quarter of 2020, the company reported a 39% year-over-year revenue increase. However, that was weaker than its full-year revenue growth rate of 43%. Even more concerning, Unity provided a full-year revenue guidance range for 2021 anticipating growth of 24% at the midpoint.</p><p><blockquote>对 Unity 的主要打击是其增长率放缓。2020年第四季度，该公司报告收入同比增长39%。然而，这低于其43%的全年收入增长率。更令人担忧的是，Unity 提供了 2021 年全年收入指导范围，预计中点增长 24%。</blockquote></p><p> I don't think investors should be worried, though. For one thing, the pandemic boosted Unity's growth in 2020. It's not surprising that growth would slow somewhat after such an exceptional year. The company also anticipates taking a one-time hit to revenue in 2021 as advertisers adjust to<b>Apple</b>'s new IDFA user identification method.</p><p><blockquote>不过，我认为投资者不必担心。首先，疫情促进了 Unity 在 2020 年的增长。在经历了如此特殊的一年后，增长会有所放缓也就不足为奇了。该公司还预计，随着广告商的调整，2021 年收入将受到一次性打击<b>苹果</b>的新IDFA用户识别方法。</blockquote></p><p> Unity still expects to generate annual revenue growth of at least 30% over the long term. Wood clearly remains a fan of the stock -- her ARK Innovation ETFscooped up more sharesrecently. I think that her optimism in this case is spot on.</p><p><blockquote>Unity 仍预计从长远来看，年收入将增长至少 30%。伍德显然仍然是该股的粉丝——她的方舟创新 ETF 最近买入了更多股票。我认为她在这种情况下的乐观是正确的。</blockquote></p><p> Vertex Pharmaceuticals</p><p><blockquote>顶点制药</blockquote></p><p> <b>Vertex Pharmaceuticals</b>(NASDAQ:VRTX)hasn't been quite as big of a problem for Wood in 2021 as Teladoc and Unity. However, thebiotech stockhas fallen more than 10% year to date. It's the seventh-largest position for the ARK Genomic Revolution ETF.</p><p><blockquote><b>顶点制药</b>（纳斯达克股票代码：VRTX）在 2021 年对伍德来说并不像 Teladoc 和 Unity 那样成为大问题。然而，生物技术股今年迄今已下跌超过 10%。这是方舟基因组革命 ETF 的第七大头寸。</blockquote></p><p> Wall Street analysts weren't happy with the Q4 results Vertex reported in February. Although the company narrowly beat revenue expectations, its adjusted earnings came in below analysts' estimates. Vertex also provided guidance for 2021 that anticipated slowing growth.</p><p><blockquote>华尔街分析师对 Vertex 二月份公布的第四季度业绩并不满意。尽管该公司的收入略微超出预期，但其调整后盈利低于分析师的预期。Vertex 还为 2021 年提供了预计增长放缓的指导。</blockquote></p><p> However, Vertex still has a big market opportunity ahead for its newest cystic fibrosis treatment, Trikafta/Kaftrio, in Europe. The triple-drug combination quickly became a blockbuster in the U.S. after winning approval. However, its growth curve in Europe will take more time because Vertex has to negotiate reimbursement deals with the healthcare regulators in each individual country.</p><p><blockquote>然而，Vertex 在欧洲的最新囊性纤维化治疗药物 Trikafta/Kaftrio 仍有巨大的市场机会。三联药组合在赢得批准后迅速在美国一鸣惊人。然而，其在欧洲的增长曲线将需要更多时间，因为 Vertex 必须与每个国家的医疗保健监管机构协商报销协议。</blockquote></p><p> I fully expect Vertex will achieve tremendous success outside of the cystic fibrosis market over the next few years. The big biotech seems really confident about the prospects for its candidate gene-editing therapy CTX001 in treating a pair of rare blood disorders: sickle cell disease and beta-thalassemia. It also has other promising pipeline candidates as well as a hefty cash stockpile. Vertex, like Teladoc and Unity, looks like a long-term winner despite its losing ways of late.</p><p><blockquote>我完全预计 Vertex 将在未来几年内在囊性纤维化市场之外取得巨大成功。这家大型生物技术公司似乎对其候选基因编辑疗法 CTX001 在治疗两种罕见血液疾病方面的前景非常有信心：镰状细胞病和β-地中海贫血。它还有其他有前途的管道候选者以及大量的现金储备。像Teladoc和Unity一样，Vertex看起来是一个长期的赢家，尽管它最近失败了。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 of Cathie Wood's Biggest Losers of 2021 That Should Still Be Huge Long-Term Winners<blockquote>凯西·伍德 (Cathie Wood) 2021 年最大的 3 个输家仍然应该是巨大的长期赢家</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 of Cathie Wood's Biggest Losers of 2021 That Should Still Be Huge Long-Term Winners<blockquote>凯西·伍德 (Cathie Wood) 2021 年最大的 3 个输家仍然应该是巨大的长期赢家</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-04-30 22:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>David Gardner, a co-founder of The Motley Fool, often says that \"winners win.\" And he's exactly right. However, he would be the first to tell you that winners don't win<i>all</i>of the time. They have their ups and downs.</p><p><blockquote>Motley Fool 的联合创始人大卫·加德纳 (David Gardner) 经常说“赢家获胜”。他说得完全正确。然而，他会第一个告诉你胜利者不会赢<i>全部</i>那个时候。他们有起起落落。</blockquote></p><p> Case in point: Cathie Wood certainly qualifies as a winner. Her ARK Invest exchange-traded funds have ranked among the best-performing ETFs in recent years. Not every stock in those funds has delivered a great return so far in 2021, though.</p><p><blockquote>典型的例子：凯西·伍德当然有资格成为赢家。她的 ARK Invest 交易所交易基金是近年来表现最好的 ETF 之一。不过，2021 年迄今为止，并非这些基金中的每只股票都能带来丰厚的回报。</blockquote></p><p> Several of the ARK Invest CEO's favorites are actually down year to date. Don't count all of those recent underperformers out just yet, though. These three are among Wood's biggest losers of 2021, and all should still be huge winners over the long run.</p><p><blockquote>ARK Invest 首席执行官最喜欢的几只股票实际上今年迄今为止都在下跌。不过，不要把最近表现不佳的公司都算在内。这三个人是伍德2021年最大的输家之一，从长远来看，他们都应该是巨大的赢家。</blockquote></p><p> Teladoc Health</p><p><blockquote>泰拉多克健康</blockquote></p><p> <b>Teladoc Health</b>(NYSE:TDOC)shares have fallen more than 15% year to date, and that's weighing on several of Wood's ETFs. Teladoc is the top holding in the<b>ARK Genomic Revolution ETF</b>, the second-largest position in the<b>ARK Innovation ETF</b>, and the fifth-largest holding in the<b>ARK Next Generation Internet ETF</b>.</p><p><blockquote><b>泰拉多克健康</b>（纽约证券交易所股票代码：TDOC）今年迄今已下跌超过 15%，这给伍德的几只 ETF 带来了压力。Teladoc 是最大的控股公司<b>方舟基因组革命 ETF</b>，第二大位置<b>方舟创新ETF</b>以及第五大持股<b>方舟下一代互联网ETF</b>.</blockquote></p><p> It appears that many investors are focusing only on the negatives for Teladoc. For example,in its Q1 update, the company reported a huge net loss and said that U.S. paid membership in the quarter slipped to 51.5 million from 51.8 million in the fourth quarter of 2020.</p><p><blockquote>许多投资者似乎只关注 Teladoc 的负面影响。例如，在第一季度更新中，该公司报告了巨额净亏损，并表示本季度美国付费会员从 2020 年第四季度的 5180 万下滑至 5150 万。</blockquote></p><p> However, that's only part of the story. Teladoc's total visits and utilization rate continue to climb. And much of that big loss was related to the company's acquisitions of Livongo and InTouch Health, deals that are already helping drive its revenue growth.</p><p><blockquote>然而，这只是故事的一部分。Teladoc 的总访问量和利用率持续攀升。这一巨额亏损很大程度上与该公司收购 Livongo 和 InTouch Health 有关，这些交易已经帮助推动了其收入增长。</blockquote></p><p> My view is that Teladoc's downturn will be temporary. The long-term opportunities for the company in virtual care remain exceptionally strong.</p><p><blockquote>我认为 Teladoc 的低迷将是暂时的。该公司在虚拟护理领域的长期机会仍然异常强劲。</blockquote></p><p> Unity Software</p><p><blockquote>Unity软件</blockquote></p><p> <b>Unity Software</b>(NYSE:U)has been an especially poor performer for Wood this year -- the stock has plunged more than 30%. The gaming platform leader ranks No. 10 among the ARK Next Generation Internet ETF's holdings and No. 12 for the ARK Innovation ETF.</p><p><blockquote><b>Unity软件</b>（纽约证券交易所股票代码：U）今年的表现尤其糟糕——该股已暴跌超过 30%。这家游戏平台领导者在方舟下一代互联网 ETF 持有的股票中排名第 10，在方舟创新 ETF 中排名第 12。</blockquote></p><p> The main knock against Unity is its slowing growth rate. In the fourth quarter of 2020, the company reported a 39% year-over-year revenue increase. However, that was weaker than its full-year revenue growth rate of 43%. Even more concerning, Unity provided a full-year revenue guidance range for 2021 anticipating growth of 24% at the midpoint.</p><p><blockquote>对 Unity 的主要打击是其增长率放缓。2020年第四季度，该公司报告收入同比增长39%。然而，这低于其43%的全年收入增长率。更令人担忧的是，Unity 提供了 2021 年全年收入指导范围，预计中点增长 24%。</blockquote></p><p> I don't think investors should be worried, though. For one thing, the pandemic boosted Unity's growth in 2020. It's not surprising that growth would slow somewhat after such an exceptional year. The company also anticipates taking a one-time hit to revenue in 2021 as advertisers adjust to<b>Apple</b>'s new IDFA user identification method.</p><p><blockquote>不过，我认为投资者不必担心。首先，疫情促进了 Unity 在 2020 年的增长。在经历了如此特殊的一年后，增长会有所放缓也就不足为奇了。该公司还预计，随着广告商的调整，2021 年收入将受到一次性打击<b>苹果</b>的新IDFA用户识别方法。</blockquote></p><p> Unity still expects to generate annual revenue growth of at least 30% over the long term. Wood clearly remains a fan of the stock -- her ARK Innovation ETFscooped up more sharesrecently. I think that her optimism in this case is spot on.</p><p><blockquote>Unity 仍预计从长远来看，年收入将增长至少 30%。伍德显然仍然是该股的粉丝——她的方舟创新 ETF 最近买入了更多股票。我认为她在这种情况下的乐观是正确的。</blockquote></p><p> Vertex Pharmaceuticals</p><p><blockquote>顶点制药</blockquote></p><p> <b>Vertex Pharmaceuticals</b>(NASDAQ:VRTX)hasn't been quite as big of a problem for Wood in 2021 as Teladoc and Unity. However, thebiotech stockhas fallen more than 10% year to date. It's the seventh-largest position for the ARK Genomic Revolution ETF.</p><p><blockquote><b>顶点制药</b>（纳斯达克股票代码：VRTX）在 2021 年对伍德来说并不像 Teladoc 和 Unity 那样成为大问题。然而，生物技术股今年迄今已下跌超过 10%。这是方舟基因组革命 ETF 的第七大头寸。</blockquote></p><p> Wall Street analysts weren't happy with the Q4 results Vertex reported in February. Although the company narrowly beat revenue expectations, its adjusted earnings came in below analysts' estimates. Vertex also provided guidance for 2021 that anticipated slowing growth.</p><p><blockquote>华尔街分析师对 Vertex 二月份公布的第四季度业绩并不满意。尽管该公司的收入略微超出预期，但其调整后盈利低于分析师的预期。Vertex 还为 2021 年提供了预计增长放缓的指导。</blockquote></p><p> However, Vertex still has a big market opportunity ahead for its newest cystic fibrosis treatment, Trikafta/Kaftrio, in Europe. The triple-drug combination quickly became a blockbuster in the U.S. after winning approval. However, its growth curve in Europe will take more time because Vertex has to negotiate reimbursement deals with the healthcare regulators in each individual country.</p><p><blockquote>然而，Vertex 在欧洲的最新囊性纤维化治疗药物 Trikafta/Kaftrio 仍有巨大的市场机会。三联药组合在赢得批准后迅速在美国一鸣惊人。然而，其在欧洲的增长曲线将需要更多时间，因为 Vertex 必须与每个国家的医疗保健监管机构协商报销协议。</blockquote></p><p> I fully expect Vertex will achieve tremendous success outside of the cystic fibrosis market over the next few years. The big biotech seems really confident about the prospects for its candidate gene-editing therapy CTX001 in treating a pair of rare blood disorders: sickle cell disease and beta-thalassemia. It also has other promising pipeline candidates as well as a hefty cash stockpile. Vertex, like Teladoc and Unity, looks like a long-term winner despite its losing ways of late.</p><p><blockquote>我完全预计 Vertex 将在未来几年内在囊性纤维化市场之外取得巨大成功。这家大型生物技术公司似乎对其候选基因编辑疗法 CTX001 在治疗两种罕见血液疾病方面的前景非常有信心：镰状细胞病和β-地中海贫血。它还有其他有前途的管道候选者以及大量的现金储备。像Teladoc和Unity一样，Vertex看起来是一个长期的赢家，尽管它最近失败了。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/04/30/3-of-cathie-woods-biggest-losers-of-2021-that-shou/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-of-cathie-woods-biggest-losers-of-2021-that-shou/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115363330","content_text":"David Gardner, a co-founder of The Motley Fool, often says that \"winners win.\" And he's exactly right. However, he would be the first to tell you that winners don't winallof the time. They have their ups and downs.\nCase in point: Cathie Wood certainly qualifies as a winner. Her ARK Invest exchange-traded funds have ranked among the best-performing ETFs in recent years. Not every stock in those funds has delivered a great return so far in 2021, though.\nSeveral of the ARK Invest CEO's favorites are actually down year to date. Don't count all of those recent underperformers out just yet, though. These three are among Wood's biggest losers of 2021, and all should still be huge winners over the long run.\nTeladoc Health\nTeladoc Health(NYSE:TDOC)shares have fallen more than 15% year to date, and that's weighing on several of Wood's ETFs. Teladoc is the top holding in theARK Genomic Revolution ETF, the second-largest position in theARK Innovation ETF, and the fifth-largest holding in theARK Next Generation Internet ETF.\nIt appears that many investors are focusing only on the negatives for Teladoc. For example,in its Q1 update, the company reported a huge net loss and said that U.S. paid membership in the quarter slipped to 51.5 million from 51.8 million in the fourth quarter of 2020.\nHowever, that's only part of the story. Teladoc's total visits and utilization rate continue to climb. And much of that big loss was related to the company's acquisitions of Livongo and InTouch Health, deals that are already helping drive its revenue growth.\nMy view is that Teladoc's downturn will be temporary. The long-term opportunities for the company in virtual care remain exceptionally strong.\nUnity Software\nUnity Software(NYSE:U)has been an especially poor performer for Wood this year -- the stock has plunged more than 30%. The gaming platform leader ranks No. 10 among the ARK Next Generation Internet ETF's holdings and No. 12 for the ARK Innovation ETF.\nThe main knock against Unity is its slowing growth rate. In the fourth quarter of 2020, the company reported a 39% year-over-year revenue increase. However, that was weaker than its full-year revenue growth rate of 43%. Even more concerning, Unity provided a full-year revenue guidance range for 2021 anticipating growth of 24% at the midpoint.\nI don't think investors should be worried, though. For one thing, the pandemic boosted Unity's growth in 2020. It's not surprising that growth would slow somewhat after such an exceptional year. The company also anticipates taking a one-time hit to revenue in 2021 as advertisers adjust toApple's new IDFA user identification method.\nUnity still expects to generate annual revenue growth of at least 30% over the long term. Wood clearly remains a fan of the stock -- her ARK Innovation ETFscooped up more sharesrecently. I think that her optimism in this case is spot on.\nVertex Pharmaceuticals\nVertex Pharmaceuticals(NASDAQ:VRTX)hasn't been quite as big of a problem for Wood in 2021 as Teladoc and Unity. However, thebiotech stockhas fallen more than 10% year to date. It's the seventh-largest position for the ARK Genomic Revolution ETF.\nWall Street analysts weren't happy with the Q4 results Vertex reported in February. Although the company narrowly beat revenue expectations, its adjusted earnings came in below analysts' estimates. Vertex also provided guidance for 2021 that anticipated slowing growth.\nHowever, Vertex still has a big market opportunity ahead for its newest cystic fibrosis treatment, Trikafta/Kaftrio, in Europe. The triple-drug combination quickly became a blockbuster in the U.S. after winning approval. However, its growth curve in Europe will take more time because Vertex has to negotiate reimbursement deals with the healthcare regulators in each individual country.\nI fully expect Vertex will achieve tremendous success outside of the cystic fibrosis market over the next few years. The big biotech seems really confident about the prospects for its candidate gene-editing therapy CTX001 in treating a pair of rare blood disorders: sickle cell disease and beta-thalassemia. It also has other promising pipeline candidates as well as a hefty cash stockpile. Vertex, like Teladoc and Unity, looks like a long-term winner despite its losing ways of late.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101496942,"gmtCreate":1619928614186,"gmtModify":1634209040980,"author":{"id":"3575030447100890","authorId":"3575030447100890","name":"Raywjj92","avatar":"https://static.tigerbbs.com/57550c84d835f65dcf57fd3bf7c5d66b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575030447100890","authorIdStr":"3575030447100890"},"themes":[],"title":"","htmlText":"Nice detailed&nbsp;article","listText":"Nice detailed&nbsp;article","text":"Nice detailed article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/101496942","repostId":"1103106179","repostType":4,"isVote":1,"tweetType":1,"viewCount":2260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103773825,"gmtCreate":1619827498567,"gmtModify":1634209707345,"author":{"id":"3575030447100890","authorId":"3575030447100890","name":"Raywjj92","avatar":"https://static.tigerbbs.com/57550c84d835f65dcf57fd3bf7c5d66b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575030447100890","authorIdStr":"3575030447100890"},"themes":[],"title":"","htmlText":"Good opportunity?&nbsp;","listText":"Good opportunity?&nbsp;","text":"Good opportunity?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/103773825","repostId":"1165708828","repostType":4,"isVote":1,"tweetType":1,"viewCount":2034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103745740,"gmtCreate":1619827235180,"gmtModify":1631884711018,"author":{"id":"3575030447100890","authorId":"3575030447100890","name":"Raywjj92","avatar":"https://static.tigerbbs.com/57550c84d835f65dcf57fd3bf7c5d66b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575030447100890","authorIdStr":"3575030447100890"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/QCOM\">$Qualcomm(QCOM)$</a>Come on Qualcomm","listText":"<a href=\"https://laohu8.com/S/QCOM\">$Qualcomm(QCOM)$</a>Come on Qualcomm","text":"$Qualcomm(QCOM)$Come on Qualcomm","images":[{"img":"https://static.tigerbbs.com/ed08922766e5a885016453299394bd3a","width":"750","height":"1300"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/103745740","isVote":1,"tweetType":1,"viewCount":1757,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":100278931,"gmtCreate":1619619175923,"gmtModify":1634211286629,"author":{"id":"3575030447100890","authorId":"3575030447100890","name":"Raywjj92","avatar":"https://static.tigerbbs.com/57550c84d835f65dcf57fd3bf7c5d66b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575030447100890","authorIdStr":"3575030447100890"},"themes":[],"title":"","htmlText":"Nice article","listText":"Nice article","text":"Nice article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/100278931","repostId":"1138128459","repostType":4,"repost":{"id":"1138128459","kind":"news","pubTimestamp":1619608043,"share":"https://www.laohunote.com/m/news/1138128459?lang=zh_CN&edition=full","pubTime":"2021-04-28 19:07","market":"us","language":"en","title":"5 Ultra-Popular Growth Stocks With 28% to 56% Upside, According to Wall Street<blockquote>华尔街称 5 只超受欢迎的成长型股票，上涨空间为 28% 至 56%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138128459","media":"Motley Fool","summary":"For 13 months, Wall Street has proved virtually unstoppable. Since hitting a bear market bottom on M","content":"<p>For 13 months, Wall Street has proved virtually unstoppable. Since hitting a bear market bottom on March 23, 2020, the broad-based<b>S&amp;P 500</b>has galloped higher by 87%, through this past weekend. This handily outpaces the average bounce-back rally from a bear-market bottom and leaves the historic average annual return for the benchmark index eating dust.</p><p><blockquote>13个月来，华尔街几乎是不可阻挡的。自2020年3月23日触及熊市底部以来，基础广泛的<b>标普500</b>上周末上涨了 87%。这轻松超过了熊市底部的平均反弹，并使基准指数的历史平均年回报率化为乌有。</blockquote></p><p> Yet even at these lofty levels, Wall Street professionals see value. Based on the consensus one-year price targets of Wall Street analysts, five of the most populargrowth stocksoffer implied upside ranging from a low of 28% to as much as 56%.</p><p><blockquote>然而，即使在这些崇高的水平上，华尔街专业人士也看到了价值。根据华尔街分析师一致的一年目标价，五只最受欢迎的成长型股票暗示上涨空间从最低的 28% 到高达 56%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d19c9dd5972bb303415e3fb9e20fb2d4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Shopify: Implied upside of 31%</p><p><blockquote>Shopify：隐含上涨空间 31%</blockquote></p><p> First up is my absolute favorite software-as-a-service (SaaS) stock,<b>Shopify</b>(NYSE:SHOP). Even after gaining more than 1,000% over the past 3.5 years, Wall Street believes the company's stock offers an additional 31% upside to $1,434 a share over the next year.</p><p><blockquote>首先是我最喜欢的软件即服务（SaaS）股票，<b>商店</b>（纽约证券交易所代码：商店）。即使在过去 3.5 年上涨超过 1,000% 之后，华尔街认为该公司的股票明年仍将上涨 31%，达到每股 1,434 美元。</blockquote></p><p> Shopify's operating model of providing cloud-based e-commerce solutions to (primarily) small businessescouldn't be in a better place at the moment. Although it was initially hit by the pandemic with virtually all other retail-oriented companies, it quickly became apparent that Shopify's e-commerce platform would be a logical beneficiary as businesses shifted course and pushed online. The result was a 96% increase in gross merchandise value (GMV) transacted across its platform in 2020 to $119.6 billion. Over the past six years, GMV has grown at a compound annual rate of 77.7%.</p><p><blockquote>Shopify 为（主要）小型企业提供基于云的电子商务解决方案的运营模式目前再好不过了。尽管 Shopify 最初与几乎所有其他面向零售的公司一起受到了疫情的打击，但随着企业转变方向并转向线上，Shopify 的电子商务平台很快就变得显而易见，它将成为一个合乎逻辑的受益者。结果是，2020 年其平台上的商品总价值 (GMV) 增长了 96%，达到 1196 亿美元。在过去的六年里，GMV以77.7%的复合年增长率增长。</blockquote></p><p> What's made Shopify tick is both the discovery of the platform by new merchants and the ability to snag worthwhile deals with major retailers. The number of consumers using the platform increased by approximately 52% last year to 457 million. Meanwhile, itpartneredwith the likes of<b>Walmart</b>&nbsp;and<b>Pinterest</b>to streamline aspects of their online sales platforms.</p><p><blockquote>让Shopify成功的是新商家对该平台的发现，以及与主要零售商达成有价值交易的能力。去年使用该平台的消费者数量增加了约52%，达到4.57亿。同时，它还与<b>沃尔玛</b>和<b>Pinterest</b>简化其在线销售平台的各个方面。</blockquote></p><p> Shopify isn't remotely inexpensive on a fundamental basis. But if it can continue to grow its GMV at these insane levels, investors will gladly pay a hefty premium to own Shopify stock.</p><p><blockquote>从根本上来说，Shopify 一点也不便宜。但如果它能够继续以这些疯狂的水平增长其 GMV，投资者将很乐意支付高额溢价来持有 Shopify 股票。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/df219df7b01fbc2aa008c455f28b99e5\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Teladoc Health: Implied upside of 40%</p><p><blockquote>Teladoc Health：隐含上涨空间为 40%</blockquote></p><p> Telemedicine giant<b>Teladoc Health</b>(NYSE:TDOC)has been exceptionally popular over the past year, for obvious reasons I'll touch on in a moment. According to Wall Street, shares of Teladoc could ascend past $250 over the next 12 months, giving it an implied upside of 40%.</p><p><blockquote>远程医疗巨头<b>泰拉多克健康</b>（纽约证券交易所股票代码：TDOC）在过去的一年里非常受欢迎，原因显而易见，我稍后会谈到。据华尔街报道，Teladoc 的股价在未来 12 个月内可能会升至 250 美元以上，隐含上涨空间为 40%。</blockquote></p><p> As you can imagine, physicians wanted to keep at-risk people and potentially infected patients out of offices and hospitals if at all possible last year. This led to Teladoc handling almost 10.6 million virtual visits in 2020, up from around 4.1 million in the previous year.</p><p><blockquote>你可以想象，去年，如果可能的话，医生们希望让高危人群和潜在感染的患者远离办公室和医院。这导致Teladoc在2020年处理了近1060万次虚拟访问，高于前一年的约410万次。</blockquote></p><p> But understand that telehealth is agame-changing healthcare modeland not just a one-year wonder because of the pandemic. It's far more convenient for patients, allows physicians to keep closer tabs on at-risk patients, and is usually billed at a lower rate than office visits, which health insurers love. These advantages are exactly why Teladoc's sales grew by an average annual rate of 74% between 2013 and 2019.</p><p><blockquote>但是要明白，远程医疗是一种改变游戏规则的医疗保健模式，而不仅仅是疫情一年的奇迹。这对患者来说方便得多，可以让医生更密切地关注高危患者，而且通常比健康保险公司喜欢的诊所就诊收费更低。这些优势正是 Teladoc 销售额在 2013 年至 2019 年间年均增长率为 74% 的原因。</blockquote></p><p> Furthermore, Teladoc has a new toy, so to speak: Itacquired leading applied health signals company Livongo Healthin early November. Livongo leans on artificial intelligence to send tips and nudges to patients with chronic illnesses. These nudges help patients make behavioral changes that result in their leading healthier lives. The addition of Livongo makes Teladoc a veritable no-brainer buy.</p><p><blockquote>此外，Teladoc 可以说有一个新玩具：它在 11 月初收购了领先的应用健康信号公司 Livongo Healthin。Livongo依靠人工智能向慢性病患者发送提示和轻推。这些推动有助于患者做出行为改变，从而过上更健康的生活。Livongo 的加入使得 Teladoc 成为名副其实的明智之举。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0e47e6b6eced3a10e200ffd777619a0c\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Snowflake: Implied upside of 28%</p><p><blockquote>雪花：隐含上涨空间为 28%</blockquote></p><p> Another high-growth stock with abundant upside according to Wall Street professionals is cloud data warehousing company<b>Snowflake</b>(NYSE:SNOW). After recently retracing to an all-time low, analysts see Snowflake gaining up to 28% to almost $301 a share over the next 12 months.</p><p><blockquote>华尔街专业人士认为，另一只具有巨大上涨空间的高增长股票是云数据仓库公司<b>雪花</b>（纽约证券交易所代码：雪）。在最近回落至历史低点后，分析师预计 Snowflake 将在未来 12 个月内上涨 28%，达到每股近 301 美元。</blockquote></p><p> As I alluded to with Shopify, we're witnessing a big push by businesses online and into the cloud, which has been a boon for most cloud infrastructure companies. Despite the worst economic downturn in decades, Snowflake grew its product revenue by 120% to $553.8 million in fiscal 2021. Although it's losing a lot of money at the moment, the services Snowflake offers should yield juicy margins as the company matures.</p><p><blockquote>正如我在Shopify中提到的，我们正在目睹企业大力推动在线和云，这对大多数云基础设施公司来说都是一个福音。尽管经历了几十年来最严重的经济衰退，Snowflake 在 2021 财年的产品收入仍增长了 120%，达到 5.538 亿美元。尽管目前亏损很多，但随着公司的成熟，雪花提供的服务应该会产生丰厚的利润。</blockquote></p><p></p><p> Arguably the most interesting thing about Snowflake is itssustainable competitive advantages. For instance, it offers a pay-as-you-go model that shuns the subscriptions that SaaS stocks often covet. By allowing its customers to pay based on their storage needs and Snowflake Compute Credits used, it's offering a highly transparent and cost-effective operating model.</p><p><blockquote>可以说，雪花最有趣的一点是它可持续的竞争优势。例如，它提供了现收现付模式，避免了SaaS股票经常觊觎的订阅。通过允许客户根据他们的存储需求和使用的雪花计算积分付费，它提供了一种高度透明和具有成本效益的运营模式。</blockquote></p><p> Even better, its platform islayered atop the most popular cloud infrastructure solutions, which makes the sharing of information seamless, regardless of storage provider.</p><p><blockquote>更好的是，它的平台位于最流行的云基础设施解决方案之上，这使得信息共享无缝，无论存储提供商是谁。</blockquote></p><p> Snowflake has some very big shoes to fill with its lofty valuation, but Wall Street believes the company can get it done.</p><p><blockquote>Snowflake 的高估值需要填补一些非常大的空缺，但华尔街相信该公司可以做到这一点。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bbafad9e87b7b7dacfefe92d4741b655\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Datadog: Implied upside of 35%</p><p><blockquote>Datadog：隐含上涨空间为 35%</blockquote></p><p> Have I mentioned that Wall Street has a thing forSaaS stocks? In addition to Shopify and Snowflake, analysts believe that application monitoring solutions provider<b>Datadog</b>(NASDAQ:DDOG)could surge to $121 a share over the next year. This implies up to 35% upside in its shares.</p><p><blockquote>我有没有提到华尔街对股票情有独钟？除了 Shopify 和 Snowflake 之外，分析师认为应用程序监控解决方案提供商<b>数据狗</b>（纳斯达克股票代码：DDOG）明年可能会飙升至每股 121 美元。这意味着其股价有高达 35% 的上涨空间。</blockquote></p><p> Keeping with the theme, Datadog looks to benefit from businesses completely shifting their strategy in the wake of the pandemic. With employees working remotely, it's become more important than ever that businesses stay on top of key metrics, oversee critical applications, and fully understand the behavior of their customers. Datadog's cloud-based solutions do all of this for its clients.</p><p><blockquote>与主题保持一致，Datadog希望从疫情后企业完全改变战略中受益。随着员工远程工作，企业掌握关键指标、监督关键应用程序并充分了解客户行为变得比以往任何时候都更加重要。Datadog基于云的解决方案为其客户做到了这一切。</blockquote></p><p> What's been most impressive about Datadog is the company's ability to attract bigger clients. While a 46% increase in customers with at least $100,000 in annual recurring revenue (ARR) is nice, the \"wow\" number is the 94% increase in the number of customers generating at least $1 million in ARR. This is a big reason the company's sales shot 66% higher in 2020 to $603.5 million.</p><p><blockquote>Datadog最令人印象深刻的是该公司吸引更大客户的能力。虽然年经常性收入(ARR)至少为10万美元的客户增加了46%是不错的，但“令人惊叹”的数字是产生至少100万美元ARR的客户数量增加了94%。这是该公司2020年销售额增长66%至6.035亿美元的一个重要原因。</blockquote></p><p> Similar to Snowflake, Datadog has a lot to prove with its lofty price-to-sales ratio. However, if it can continue to grow its sales by more than 30% annually, there'sno reason Wall Street's price target isn't within reach.</p><p><blockquote>与 Snowflake 类似，Datadog 的高市销率有很多需要证明的地方。然而，如果它的销售额能够继续以每年30%以上的速度增长，那么华尔街的价格目标就没有理由无法实现。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/99b3853458b2424e2901821012f5502f\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Coinbase: Implied upside of 56%</p><p><blockquote>Coinbase：隐含上涨空间 56%</blockquote></p><p> Finally, recent initial public offering<b>Coinbase</b>(NASDAQ:COIN)offers the highest perceived upside among these five fast-growing companies. Though there were only four price targets listed through this past weekend, a lofty target of $600 a share skewed the consensus up to $456 a share. This suggests Coinbase could gain 56% over the coming 12 months.</p><p><blockquote>最后，最近的首次公开募股<b>比特币基地</b>（纳斯达克股票代码：COIN）在这五家快速增长的公司中提供了最高的感知上涨空间。尽管截至上周末只有四个目标价，但每股 600 美元的高目标使共识偏离至每股 456 美元。这表明 Coinbase 在未来 12 个月内可能会上涨 56%。</blockquote></p><p> There's no doubt that Coinbase has benefited from the euphoria surrounding cryptocurrencies like<b>Bitcoin</b>and&nbsp;<b>Ethereum</b>. With both rallying to new highs this year, Coinbase recorded $1.8 billion in revenue in the first quarter. For some context, that's more revenue than it had generated in the previous 24 months combined!</p><p><blockquote>毫无疑问，Coinbase 受益于围绕加密货币的狂热，例如<b>比特币</b>和<b>以太币</b>随着今年两者都创下新高，Coinbase 第一季度的收入达到 18 亿美元。在某些情况下，这比它过去 24 个月产生的收入总和还要多!</blockquote></p><p> However, unlike the other popular companies listed here,Coinbase's advantages look flimsy, at best. It runs the risk of competing crypto brokerages undercutting its fees, which could reduce its operating margins and growth rate dramatically over time.</p><p><blockquote>然而，与这里列出的其他热门公司不同，Coinbase 的优势充其量看起来很脆弱。它面临着竞争加密货币经纪公司降低费用的风险，这可能会随着时间的推移大幅降低其营业利润率和增长率。</blockquote></p><p> Furthermore,its business model looks to be built upon euphoria&nbsp;rather than innovation. With most of its revenue coming from Bitcoin and Ethereum trading, it's worrisome to see what happens when the price of these key assets stops rising. In a two-year stretch where Bitcoin lost 80% of its value, Coinbase saw its revenue nearly get halved.</p><p><blockquote>此外， 它的商业模式看起来建立在兴奋而不是创新的基础上。由于其大部分收入来自比特币和以太币交易，当这些关键资产的价格停止上涨时会发生什么令人担忧。在比特币价值损失 80% 的两年时间里，Coinbase 的收入几乎减半。</blockquote></p><p> In sum, Wall Street may be bullish on Coinbase, but this Fool isn't.</p><p><blockquote>总之，华尔街可能看好比特币基地，但这个傻瓜并不看好。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Growth Stocks With 28% to 56% Upside, According to Wall Street<blockquote>华尔街称 5 只超受欢迎的成长型股票，上涨空间为 28% 至 56%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Growth Stocks With 28% to 56% Upside, According to Wall Street<blockquote>华尔街称 5 只超受欢迎的成长型股票，上涨空间为 28% 至 56%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-04-28 19:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>For 13 months, Wall Street has proved virtually unstoppable. Since hitting a bear market bottom on March 23, 2020, the broad-based<b>S&amp;P 500</b>has galloped higher by 87%, through this past weekend. This handily outpaces the average bounce-back rally from a bear-market bottom and leaves the historic average annual return for the benchmark index eating dust.</p><p><blockquote>13个月来，华尔街几乎是不可阻挡的。自2020年3月23日触及熊市底部以来，基础广泛的<b>标普500</b>上周末上涨了 87%。这轻松超过了熊市底部的平均反弹，并使基准指数的历史平均年回报率化为乌有。</blockquote></p><p> Yet even at these lofty levels, Wall Street professionals see value. Based on the consensus one-year price targets of Wall Street analysts, five of the most populargrowth stocksoffer implied upside ranging from a low of 28% to as much as 56%.</p><p><blockquote>然而，即使在这些崇高的水平上，华尔街专业人士也看到了价值。根据华尔街分析师一致的一年目标价，五只最受欢迎的成长型股票暗示上涨空间从最低的 28% 到高达 56%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d19c9dd5972bb303415e3fb9e20fb2d4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Shopify: Implied upside of 31%</p><p><blockquote>Shopify：隐含上涨空间 31%</blockquote></p><p> First up is my absolute favorite software-as-a-service (SaaS) stock,<b>Shopify</b>(NYSE:SHOP). Even after gaining more than 1,000% over the past 3.5 years, Wall Street believes the company's stock offers an additional 31% upside to $1,434 a share over the next year.</p><p><blockquote>首先是我最喜欢的软件即服务（SaaS）股票，<b>商店</b>（纽约证券交易所代码：商店）。即使在过去 3.5 年上涨超过 1,000% 之后，华尔街认为该公司的股票明年仍将上涨 31%，达到每股 1,434 美元。</blockquote></p><p> Shopify's operating model of providing cloud-based e-commerce solutions to (primarily) small businessescouldn't be in a better place at the moment. Although it was initially hit by the pandemic with virtually all other retail-oriented companies, it quickly became apparent that Shopify's e-commerce platform would be a logical beneficiary as businesses shifted course and pushed online. The result was a 96% increase in gross merchandise value (GMV) transacted across its platform in 2020 to $119.6 billion. Over the past six years, GMV has grown at a compound annual rate of 77.7%.</p><p><blockquote>Shopify 为（主要）小型企业提供基于云的电子商务解决方案的运营模式目前再好不过了。尽管 Shopify 最初与几乎所有其他面向零售的公司一起受到了疫情的打击，但随着企业转变方向并转向线上，Shopify 的电子商务平台很快就变得显而易见，它将成为一个合乎逻辑的受益者。结果是，2020 年其平台上的商品总价值 (GMV) 增长了 96%，达到 1196 亿美元。在过去的六年里，GMV以77.7%的复合年增长率增长。</blockquote></p><p> What's made Shopify tick is both the discovery of the platform by new merchants and the ability to snag worthwhile deals with major retailers. The number of consumers using the platform increased by approximately 52% last year to 457 million. Meanwhile, itpartneredwith the likes of<b>Walmart</b>&nbsp;and<b>Pinterest</b>to streamline aspects of their online sales platforms.</p><p><blockquote>让Shopify成功的是新商家对该平台的发现，以及与主要零售商达成有价值交易的能力。去年使用该平台的消费者数量增加了约52%，达到4.57亿。同时，它还与<b>沃尔玛</b>和<b>Pinterest</b>简化其在线销售平台的各个方面。</blockquote></p><p> Shopify isn't remotely inexpensive on a fundamental basis. But if it can continue to grow its GMV at these insane levels, investors will gladly pay a hefty premium to own Shopify stock.</p><p><blockquote>从根本上来说，Shopify 一点也不便宜。但如果它能够继续以这些疯狂的水平增长其 GMV，投资者将很乐意支付高额溢价来持有 Shopify 股票。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/df219df7b01fbc2aa008c455f28b99e5\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Teladoc Health: Implied upside of 40%</p><p><blockquote>Teladoc Health：隐含上涨空间为 40%</blockquote></p><p> Telemedicine giant<b>Teladoc Health</b>(NYSE:TDOC)has been exceptionally popular over the past year, for obvious reasons I'll touch on in a moment. According to Wall Street, shares of Teladoc could ascend past $250 over the next 12 months, giving it an implied upside of 40%.</p><p><blockquote>远程医疗巨头<b>泰拉多克健康</b>（纽约证券交易所股票代码：TDOC）在过去的一年里非常受欢迎，原因显而易见，我稍后会谈到。据华尔街报道，Teladoc 的股价在未来 12 个月内可能会升至 250 美元以上，隐含上涨空间为 40%。</blockquote></p><p> As you can imagine, physicians wanted to keep at-risk people and potentially infected patients out of offices and hospitals if at all possible last year. This led to Teladoc handling almost 10.6 million virtual visits in 2020, up from around 4.1 million in the previous year.</p><p><blockquote>你可以想象，去年，如果可能的话，医生们希望让高危人群和潜在感染的患者远离办公室和医院。这导致Teladoc在2020年处理了近1060万次虚拟访问，高于前一年的约410万次。</blockquote></p><p> But understand that telehealth is agame-changing healthcare modeland not just a one-year wonder because of the pandemic. It's far more convenient for patients, allows physicians to keep closer tabs on at-risk patients, and is usually billed at a lower rate than office visits, which health insurers love. These advantages are exactly why Teladoc's sales grew by an average annual rate of 74% between 2013 and 2019.</p><p><blockquote>但是要明白，远程医疗是一种改变游戏规则的医疗保健模式，而不仅仅是疫情一年的奇迹。这对患者来说方便得多，可以让医生更密切地关注高危患者，而且通常比健康保险公司喜欢的诊所就诊收费更低。这些优势正是 Teladoc 销售额在 2013 年至 2019 年间年均增长率为 74% 的原因。</blockquote></p><p> Furthermore, Teladoc has a new toy, so to speak: Itacquired leading applied health signals company Livongo Healthin early November. Livongo leans on artificial intelligence to send tips and nudges to patients with chronic illnesses. These nudges help patients make behavioral changes that result in their leading healthier lives. The addition of Livongo makes Teladoc a veritable no-brainer buy.</p><p><blockquote>此外，Teladoc 可以说有一个新玩具：它在 11 月初收购了领先的应用健康信号公司 Livongo Healthin。Livongo依靠人工智能向慢性病患者发送提示和轻推。这些推动有助于患者做出行为改变，从而过上更健康的生活。Livongo 的加入使得 Teladoc 成为名副其实的明智之举。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0e47e6b6eced3a10e200ffd777619a0c\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Snowflake: Implied upside of 28%</p><p><blockquote>雪花：隐含上涨空间为 28%</blockquote></p><p> Another high-growth stock with abundant upside according to Wall Street professionals is cloud data warehousing company<b>Snowflake</b>(NYSE:SNOW). After recently retracing to an all-time low, analysts see Snowflake gaining up to 28% to almost $301 a share over the next 12 months.</p><p><blockquote>华尔街专业人士认为，另一只具有巨大上涨空间的高增长股票是云数据仓库公司<b>雪花</b>（纽约证券交易所代码：雪）。在最近回落至历史低点后，分析师预计 Snowflake 将在未来 12 个月内上涨 28%，达到每股近 301 美元。</blockquote></p><p> As I alluded to with Shopify, we're witnessing a big push by businesses online and into the cloud, which has been a boon for most cloud infrastructure companies. Despite the worst economic downturn in decades, Snowflake grew its product revenue by 120% to $553.8 million in fiscal 2021. Although it's losing a lot of money at the moment, the services Snowflake offers should yield juicy margins as the company matures.</p><p><blockquote>正如我在Shopify中提到的，我们正在目睹企业大力推动在线和云，这对大多数云基础设施公司来说都是一个福音。尽管经历了几十年来最严重的经济衰退，Snowflake 在 2021 财年的产品收入仍增长了 120%，达到 5.538 亿美元。尽管目前亏损很多，但随着公司的成熟，雪花提供的服务应该会产生丰厚的利润。</blockquote></p><p></p><p> Arguably the most interesting thing about Snowflake is itssustainable competitive advantages. For instance, it offers a pay-as-you-go model that shuns the subscriptions that SaaS stocks often covet. By allowing its customers to pay based on their storage needs and Snowflake Compute Credits used, it's offering a highly transparent and cost-effective operating model.</p><p><blockquote>可以说，雪花最有趣的一点是它可持续的竞争优势。例如，它提供了现收现付模式，避免了SaaS股票经常觊觎的订阅。通过允许客户根据他们的存储需求和使用的雪花计算积分付费，它提供了一种高度透明和具有成本效益的运营模式。</blockquote></p><p> Even better, its platform islayered atop the most popular cloud infrastructure solutions, which makes the sharing of information seamless, regardless of storage provider.</p><p><blockquote>更好的是，它的平台位于最流行的云基础设施解决方案之上，这使得信息共享无缝，无论存储提供商是谁。</blockquote></p><p> Snowflake has some very big shoes to fill with its lofty valuation, but Wall Street believes the company can get it done.</p><p><blockquote>Snowflake 的高估值需要填补一些非常大的空缺，但华尔街相信该公司可以做到这一点。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bbafad9e87b7b7dacfefe92d4741b655\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Datadog: Implied upside of 35%</p><p><blockquote>Datadog：隐含上涨空间为 35%</blockquote></p><p> Have I mentioned that Wall Street has a thing forSaaS stocks? In addition to Shopify and Snowflake, analysts believe that application monitoring solutions provider<b>Datadog</b>(NASDAQ:DDOG)could surge to $121 a share over the next year. This implies up to 35% upside in its shares.</p><p><blockquote>我有没有提到华尔街对股票情有独钟？除了 Shopify 和 Snowflake 之外，分析师认为应用程序监控解决方案提供商<b>数据狗</b>（纳斯达克股票代码：DDOG）明年可能会飙升至每股 121 美元。这意味着其股价有高达 35% 的上涨空间。</blockquote></p><p> Keeping with the theme, Datadog looks to benefit from businesses completely shifting their strategy in the wake of the pandemic. With employees working remotely, it's become more important than ever that businesses stay on top of key metrics, oversee critical applications, and fully understand the behavior of their customers. Datadog's cloud-based solutions do all of this for its clients.</p><p><blockquote>与主题保持一致，Datadog希望从疫情后企业完全改变战略中受益。随着员工远程工作，企业掌握关键指标、监督关键应用程序并充分了解客户行为变得比以往任何时候都更加重要。Datadog基于云的解决方案为其客户做到了这一切。</blockquote></p><p> What's been most impressive about Datadog is the company's ability to attract bigger clients. While a 46% increase in customers with at least $100,000 in annual recurring revenue (ARR) is nice, the \"wow\" number is the 94% increase in the number of customers generating at least $1 million in ARR. This is a big reason the company's sales shot 66% higher in 2020 to $603.5 million.</p><p><blockquote>Datadog最令人印象深刻的是该公司吸引更大客户的能力。虽然年经常性收入(ARR)至少为10万美元的客户增加了46%是不错的，但“令人惊叹”的数字是产生至少100万美元ARR的客户数量增加了94%。这是该公司2020年销售额增长66%至6.035亿美元的一个重要原因。</blockquote></p><p> Similar to Snowflake, Datadog has a lot to prove with its lofty price-to-sales ratio. However, if it can continue to grow its sales by more than 30% annually, there'sno reason Wall Street's price target isn't within reach.</p><p><blockquote>与 Snowflake 类似，Datadog 的高市销率有很多需要证明的地方。然而，如果它的销售额能够继续以每年30%以上的速度增长，那么华尔街的价格目标就没有理由无法实现。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/99b3853458b2424e2901821012f5502f\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> IMAGE SOURCE: GETTY IMAGES.</p><p><blockquote>图片来源：盖蒂图片社。</blockquote></p><p> Coinbase: Implied upside of 56%</p><p><blockquote>Coinbase：隐含上涨空间 56%</blockquote></p><p> Finally, recent initial public offering<b>Coinbase</b>(NASDAQ:COIN)offers the highest perceived upside among these five fast-growing companies. Though there were only four price targets listed through this past weekend, a lofty target of $600 a share skewed the consensus up to $456 a share. This suggests Coinbase could gain 56% over the coming 12 months.</p><p><blockquote>最后，最近的首次公开募股<b>比特币基地</b>（纳斯达克股票代码：COIN）在这五家快速增长的公司中提供了最高的感知上涨空间。尽管截至上周末只有四个目标价，但每股 600 美元的高目标使共识偏离至每股 456 美元。这表明 Coinbase 在未来 12 个月内可能会上涨 56%。</blockquote></p><p> There's no doubt that Coinbase has benefited from the euphoria surrounding cryptocurrencies like<b>Bitcoin</b>and&nbsp;<b>Ethereum</b>. With both rallying to new highs this year, Coinbase recorded $1.8 billion in revenue in the first quarter. For some context, that's more revenue than it had generated in the previous 24 months combined!</p><p><blockquote>毫无疑问，Coinbase 受益于围绕加密货币的狂热，例如<b>比特币</b>和<b>以太币</b>随着今年两者都创下新高，Coinbase 第一季度的收入达到 18 亿美元。在某些情况下，这比它过去 24 个月产生的收入总和还要多!</blockquote></p><p> However, unlike the other popular companies listed here,Coinbase's advantages look flimsy, at best. It runs the risk of competing crypto brokerages undercutting its fees, which could reduce its operating margins and growth rate dramatically over time.</p><p><blockquote>然而，与这里列出的其他热门公司不同，Coinbase 的优势充其量看起来很脆弱。它面临着竞争加密货币经纪公司降低费用的风险，这可能会随着时间的推移大幅降低其营业利润率和增长率。</blockquote></p><p> Furthermore,its business model looks to be built upon euphoria&nbsp;rather than innovation. With most of its revenue coming from Bitcoin and Ethereum trading, it's worrisome to see what happens when the price of these key assets stops rising. In a two-year stretch where Bitcoin lost 80% of its value, Coinbase saw its revenue nearly get halved.</p><p><blockquote>此外， 它的商业模式看起来建立在兴奋而不是创新的基础上。由于其大部分收入来自比特币和以太币交易，当这些关键资产的价格停止上涨时会发生什么令人担忧。在比特币价值损失 80% 的两年时间里，Coinbase 的收入几乎减半。</blockquote></p><p> In sum, Wall Street may be bullish on Coinbase, but this Fool isn't.</p><p><blockquote>总之，华尔街可能看好比特币基地，但这个傻瓜并不看好。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/04/28/5-growth-stocks-with-28-to-56-upside-wall-street/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SHOP":"Shopify Inc","TDOC":"Teladoc Health Inc.","DDOG":"Datadog","COIN":"Coinbase Global, Inc.","SNOW":"Snowflake"},"source_url":"https://www.fool.com/investing/2021/04/28/5-growth-stocks-with-28-to-56-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138128459","content_text":"For 13 months, Wall Street has proved virtually unstoppable. Since hitting a bear market bottom on March 23, 2020, the broad-basedS&P 500has galloped higher by 87%, through this past weekend. This handily outpaces the average bounce-back rally from a bear-market bottom and leaves the historic average annual return for the benchmark index eating dust.\nYet even at these lofty levels, Wall Street professionals see value. Based on the consensus one-year price targets of Wall Street analysts, five of the most populargrowth stocksoffer implied upside ranging from a low of 28% to as much as 56%.\n\nIMAGE SOURCE: GETTY IMAGES.\nShopify: Implied upside of 31%\nFirst up is my absolute favorite software-as-a-service (SaaS) stock,Shopify(NYSE:SHOP). Even after gaining more than 1,000% over the past 3.5 years, Wall Street believes the company's stock offers an additional 31% upside to $1,434 a share over the next year.\nShopify's operating model of providing cloud-based e-commerce solutions to (primarily) small businessescouldn't be in a better place at the moment. Although it was initially hit by the pandemic with virtually all other retail-oriented companies, it quickly became apparent that Shopify's e-commerce platform would be a logical beneficiary as businesses shifted course and pushed online. The result was a 96% increase in gross merchandise value (GMV) transacted across its platform in 2020 to $119.6 billion. Over the past six years, GMV has grown at a compound annual rate of 77.7%.\nWhat's made Shopify tick is both the discovery of the platform by new merchants and the ability to snag worthwhile deals with major retailers. The number of consumers using the platform increased by approximately 52% last year to 457 million. Meanwhile, itpartneredwith the likes ofWalmart andPinterestto streamline aspects of their online sales platforms.\nShopify isn't remotely inexpensive on a fundamental basis. But if it can continue to grow its GMV at these insane levels, investors will gladly pay a hefty premium to own Shopify stock.\n\nIMAGE SOURCE: GETTY IMAGES.\nTeladoc Health: Implied upside of 40%\nTelemedicine giantTeladoc Health(NYSE:TDOC)has been exceptionally popular over the past year, for obvious reasons I'll touch on in a moment. According to Wall Street, shares of Teladoc could ascend past $250 over the next 12 months, giving it an implied upside of 40%.\nAs you can imagine, physicians wanted to keep at-risk people and potentially infected patients out of offices and hospitals if at all possible last year. This led to Teladoc handling almost 10.6 million virtual visits in 2020, up from around 4.1 million in the previous year.\nBut understand that telehealth is agame-changing healthcare modeland not just a one-year wonder because of the pandemic. It's far more convenient for patients, allows physicians to keep closer tabs on at-risk patients, and is usually billed at a lower rate than office visits, which health insurers love. These advantages are exactly why Teladoc's sales grew by an average annual rate of 74% between 2013 and 2019.\nFurthermore, Teladoc has a new toy, so to speak: Itacquired leading applied health signals company Livongo Healthin early November. Livongo leans on artificial intelligence to send tips and nudges to patients with chronic illnesses. These nudges help patients make behavioral changes that result in their leading healthier lives. The addition of Livongo makes Teladoc a veritable no-brainer buy.\n\nIMAGE SOURCE: GETTY IMAGES.\nSnowflake: Implied upside of 28%\nAnother high-growth stock with abundant upside according to Wall Street professionals is cloud data warehousing companySnowflake(NYSE:SNOW). After recently retracing to an all-time low, analysts see Snowflake gaining up to 28% to almost $301 a share over the next 12 months.\nAs I alluded to with Shopify, we're witnessing a big push by businesses online and into the cloud, which has been a boon for most cloud infrastructure companies. Despite the worst economic downturn in decades, Snowflake grew its product revenue by 120% to $553.8 million in fiscal 2021. Although it's losing a lot of money at the moment, the services Snowflake offers should yield juicy margins as the company matures.\nArguably the most interesting thing about Snowflake is itssustainable competitive advantages. For instance, it offers a pay-as-you-go model that shuns the subscriptions that SaaS stocks often covet. By allowing its customers to pay based on their storage needs and Snowflake Compute Credits used, it's offering a highly transparent and cost-effective operating model.\nEven better, its platform islayered atop the most popular cloud infrastructure solutions, which makes the sharing of information seamless, regardless of storage provider.\nSnowflake has some very big shoes to fill with its lofty valuation, but Wall Street believes the company can get it done.\n\nIMAGE SOURCE: GETTY IMAGES.\nDatadog: Implied upside of 35%\nHave I mentioned that Wall Street has a thing forSaaS stocks? In addition to Shopify and Snowflake, analysts believe that application monitoring solutions providerDatadog(NASDAQ:DDOG)could surge to $121 a share over the next year. This implies up to 35% upside in its shares.\nKeeping with the theme, Datadog looks to benefit from businesses completely shifting their strategy in the wake of the pandemic. With employees working remotely, it's become more important than ever that businesses stay on top of key metrics, oversee critical applications, and fully understand the behavior of their customers. Datadog's cloud-based solutions do all of this for its clients.\nWhat's been most impressive about Datadog is the company's ability to attract bigger clients. While a 46% increase in customers with at least $100,000 in annual recurring revenue (ARR) is nice, the \"wow\" number is the 94% increase in the number of customers generating at least $1 million in ARR. This is a big reason the company's sales shot 66% higher in 2020 to $603.5 million.\nSimilar to Snowflake, Datadog has a lot to prove with its lofty price-to-sales ratio. However, if it can continue to grow its sales by more than 30% annually, there'sno reason Wall Street's price target isn't within reach.\n\nIMAGE SOURCE: GETTY IMAGES.\nCoinbase: Implied upside of 56%\nFinally, recent initial public offeringCoinbase(NASDAQ:COIN)offers the highest perceived upside among these five fast-growing companies. Though there were only four price targets listed through this past weekend, a lofty target of $600 a share skewed the consensus up to $456 a share. This suggests Coinbase could gain 56% over the coming 12 months.\nThere's no doubt that Coinbase has benefited from the euphoria surrounding cryptocurrencies likeBitcoinand Ethereum. With both rallying to new highs this year, Coinbase recorded $1.8 billion in revenue in the first quarter. For some context, that's more revenue than it had generated in the previous 24 months combined!\nHowever, unlike the other popular companies listed here,Coinbase's advantages look flimsy, at best. It runs the risk of competing crypto brokerages undercutting its fees, which could reduce its operating margins and growth rate dramatically over time.\nFurthermore,its business model looks to be built upon euphoria rather than innovation. With most of its revenue coming from Bitcoin and Ethereum trading, it's worrisome to see what happens when the price of these key assets stops rising. In a two-year stretch where Bitcoin lost 80% of its value, Coinbase saw its revenue nearly get halved.\nIn sum, Wall Street may be bullish on Coinbase, but this Fool isn't.","news_type":1,"symbols_score_info":{"COIN":0.9,"SNOW":0.9,"TDOC":0.9,"DDOG":0.9,"SHOP":0.9}},"isVote":1,"tweetType":1,"viewCount":1567,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386924555,"gmtCreate":1613128927477,"gmtModify":1634554417319,"author":{"id":"3575030447100890","authorId":"3575030447100890","name":"Raywjj92","avatar":"https://static.tigerbbs.com/57550c84d835f65dcf57fd3bf7c5d66b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575030447100890","authorIdStr":"3575030447100890"},"themes":[],"title":"","htmlText":"Great article","listText":"Great article","text":"Great article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386924555","repostId":"2110026963","repostType":4,"isVote":1,"tweetType":1,"viewCount":1967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}